SK136596A3 - New opioid peptide analogs with mixed mu agonist/delta antagonist properties - Google Patents
New opioid peptide analogs with mixed mu agonist/delta antagonist properties Download PDFInfo
- Publication number
- SK136596A3 SK136596A3 SK1365-96A SK136596A SK136596A3 SK 136596 A3 SK136596 A3 SK 136596A3 SK 136596 A SK136596 A SK 136596A SK 136596 A3 SK136596 A3 SK 136596A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pro
- nal
- orn
- compound
- tyr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9401596A SE9401596D0 (sv) | 1994-05-06 | 1994-05-06 | New compounds |
| PCT/SE1995/000462 WO1995030694A1 (en) | 1994-05-06 | 1995-04-27 | New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK136596A3 true SK136596A3 (en) | 1997-06-04 |
Family
ID=20393941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1365-96A SK136596A3 (en) | 1994-05-06 | 1995-04-27 | New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5786447A (sv) |
| EP (1) | EP0763062A1 (sv) |
| JP (1) | JPH10500404A (sv) |
| CN (1) | CN1147819A (sv) |
| AU (1) | AU688040B2 (sv) |
| BR (1) | BR9507620A (sv) |
| CA (1) | CA2188670A1 (sv) |
| FI (1) | FI964443A (sv) |
| HU (1) | HU9603065D0 (sv) |
| IL (1) | IL113441A0 (sv) |
| IS (1) | IS4377A (sv) |
| MX (1) | MX9605352A (sv) |
| NO (1) | NO964670D0 (sv) |
| NZ (1) | NZ285476A (sv) |
| PL (1) | PL317049A1 (sv) |
| SE (1) | SE9401596D0 (sv) |
| SK (1) | SK136596A3 (sv) |
| WO (1) | WO1995030694A1 (sv) |
| ZA (1) | ZA953315B (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| AUPP616498A0 (en) * | 1998-09-25 | 1998-10-15 | University Of Queensland, The | Synthesis of cyclic peptides |
| US10010617B2 (en) * | 2011-05-18 | 2018-07-03 | Eumederis Pharmaceuticals, Inc. | Peptide pharmaceuticals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0680079B2 (ja) * | 1984-11-09 | 1994-10-12 | エーザイ株式会社 | ポリペプチド |
-
1994
- 1994-05-06 SE SE9401596A patent/SE9401596D0/sv unknown
-
1995
- 1995-04-20 IL IL11344195A patent/IL113441A0/xx unknown
- 1995-04-24 ZA ZA953315A patent/ZA953315B/xx unknown
- 1995-04-27 MX MX9605352A patent/MX9605352A/es unknown
- 1995-04-27 SK SK1365-96A patent/SK136596A3/sk unknown
- 1995-04-27 EP EP95918807A patent/EP0763062A1/en not_active Withdrawn
- 1995-04-27 WO PCT/SE1995/000462 patent/WO1995030694A1/en not_active Application Discontinuation
- 1995-04-27 CA CA002188670A patent/CA2188670A1/en not_active Abandoned
- 1995-04-27 BR BR9507620A patent/BR9507620A/pt not_active Application Discontinuation
- 1995-04-27 PL PL95317049A patent/PL317049A1/xx unknown
- 1995-04-27 NZ NZ285476A patent/NZ285476A/en unknown
- 1995-04-27 AU AU24583/95A patent/AU688040B2/en not_active Ceased
- 1995-04-27 HU HU9603065A patent/HU9603065D0/hu unknown
- 1995-04-27 CN CN95192952A patent/CN1147819A/zh active Pending
- 1995-04-27 JP JP7528880A patent/JPH10500404A/ja active Pending
- 1995-04-27 US US08/448,472 patent/US5786447A/en not_active Expired - Fee Related
-
1996
- 1996-10-21 IS IS4377A patent/IS4377A/is unknown
- 1996-11-05 FI FI964443A patent/FI964443A/sv unknown
- 1996-11-05 NO NO964670A patent/NO964670D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US5786447A (en) | 1998-07-28 |
| IS4377A (is) | 1996-10-21 |
| WO1995030694A1 (en) | 1995-11-16 |
| EP0763062A1 (en) | 1997-03-19 |
| IL113441A0 (en) | 1995-07-31 |
| BR9507620A (pt) | 1997-08-19 |
| NZ285476A (en) | 1998-04-27 |
| CA2188670A1 (en) | 1995-11-16 |
| FI964443A0 (sv) | 1996-11-05 |
| CN1147819A (zh) | 1997-04-16 |
| FI964443A (sv) | 1996-11-05 |
| NO964670L (no) | 1996-11-05 |
| AU2458395A (en) | 1995-11-29 |
| PL317049A1 (en) | 1997-03-03 |
| SE9401596D0 (sv) | 1994-05-06 |
| MX9605352A (es) | 1997-12-31 |
| HU9603065D0 (en) | 1997-01-28 |
| JPH10500404A (ja) | 1998-01-13 |
| ZA953315B (en) | 1995-11-06 |
| AU688040B2 (en) | 1998-03-05 |
| NO964670D0 (no) | 1996-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU741216B2 (en) | Phenethylamine derivatives | |
| FI77875C (sv) | Förfarande för framställning av nya terapeutiskt användbara peptider. | |
| DK147851B (da) | Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr | |
| CA2171446C (en) | Pseudo- and non-peptide bradykinin receptor antagonists | |
| AP508A (en) | Novel opioid analogs that are 9 (delta) opioid receptor antagonists, their syntheis and their use as analgesic and immunosupressive compounds. | |
| Rivier et al. | Gonadotropin-releasing hormone antagonists: novel members of the azaline B family | |
| US5817756A (en) | Pseudo- and non-peptide bradykinin receptor antagonists | |
| HU180723B (en) | Process for producing pentapeptide derivatives of analgesie activity | |
| US5811400A (en) | Peptide derivatives with δ opioid receptor antagonist or mixed μ agδ antagonist effects | |
| US5786335A (en) | Sulfhydryl containing peptides for treating vascular disease | |
| SK136596A3 (en) | New opioid peptide analogs with mixed mu agonist/delta antagonist properties | |
| Marseigne et al. | Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue | |
| US5663148A (en) | Anaphylatoxin receptor ligands containing lipophilic residues | |
| JP3583928B2 (ja) | フェネチルアミン誘導体 | |
| US4501733A (en) | Polypeptides, a process for their preparation, their use, and a _process for the purification of polypeptides | |
| CA2118253A1 (en) | Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds | |
| CA1131217A (en) | Psycho-pharmacological peptides | |
| HRP930498A2 (en) | Glycine derivatives |